Haloperidol and Other Antipsychotics Exposure before Endometrial Cancer Diagnosis: A Population-based Case-control...

Area of Science:

• Oncology
• Pharmacology
• Epidemiology

Background:

• Endometrial cancer is a prevalent female malignancy globally.
• The relationship between antipsychotic medication use and endometrial cancer risk requires further elucidation.

Purpose of the Study:

• To investigate the association between specific antipsychotic drug exposure and endometrial cancer incidence.
• To analyze the impact of antipsychotic use on the mortality rates of endometrial cancer patients.

Main Methods:

• A population-based case-control study utilized Taiwan's National Health Insurance Research Database.
• Data from over 14 million females were analyzed, identifying 9,502 with endometrial cancer.
• Exposure to seven antipsychotics, including haloperidol, was assessed up to three years prior to diagnosis.

Main Results:

• Haloperidol use was significantly more common in endometrial cancer patients compared to controls (OR 1.75, 95% CI 1.31-2.34).
• Haloperidol users exhibited a higher 5-year mortality rate post-endometrial cancer diagnosis.
• Other antipsychotics did not show a significant association with endometrial cancer risk.

Conclusions:

• A notable correlation exists between haloperidol use and endometrial cancer development.
• Further research is necessary to understand the pathological mechanisms underlying this association.